Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication April 26, 2021
- Published online September 1, 2021.
Article Versions
- Latest version (May 15, 2021 - 04:00).
- Latest version (July 1, 2021 - 04:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2021 The Journal of Rheumatology
Author Information
- Jette A. van Lint1⇑,
- Naomi T. Jessurun1,
- Sander W. Tas2,
- Bart J.F. van den Bemt3,
- Michael T. Nurmohamed4,
- Martijn B.A. van Doorn5,
- Phyllis I. Spuls6,
- Astrid M. van Tubergen7,
- Peter M. ten Klooster8,
- Eugene P. van Puijenbroek9,
- Frank Hoentjen10 and
- Harald E. Vonkeman11
- 1J.A. van Lint, PharmD, N.T. Jessurun, PharmD, Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch;
- 2S.W. Tas, MD, PhD, Department of Rheumatology & Clinical Immunology, Amsterdam UMC, location Academic Medical Center, University of Amsterdam, Amsterdam Infection & Immunity Institute and Amsterdam Rheumatology & immunology Center (ARC), Amsterdam;
- 3B.J.F. van den Bemt, PharmD, Prof. Dr., Department of Pharmacy, Sint Maartenskliniek, and Department of Pharmacy, Radboud University Medical Center, Nijmegen;
- 4M.T. Nurmohamed, MD, Prof. Dr., Amsterdam Rheumatology & immunology Center (ARC), Reade, and Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam;
- 5M.B. van Doorn, MD, PhD, Department of Dermatology, Erasmus MC, University Medical Center, Rotterdam;
- 6P.I. Spuls, MD, Prof. Dr., Department of Dermatology, Public Health and Epidemiology, Immunity and Infections, Amsterdam UMC, location Academic Medical Center, Amsterdam;
- 7A.M. van Tubergen, MD, Prof. Dr., Department of Rheumatology, Maastricht University Medical Center, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht;
- 8P.M. ten Klooster, PhD, Transparency in Healthcare BV, Hengelo, and Department of Psychology, Health & Technology, University of Twente, Enschede;
- 9E.P. van Puijenbroek, MD, Prof. Dr., Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch, and Department of Pharmacotherapy, Epidemiology & Economics, University of Groningen, Groningen;
- 10F. Hoentjen, MD, PhD, Department of Gastroenterology, Radboud University Medical Center, Nijmegen;
- 11H.E. Vonkeman, MD, PhD, Department of Psychology, Health & Technology, University of Twente, and Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, the Netherlands.
- Address correspondence to J.A. van Lint, Netherlands Pharmacovigilance Centre Lareb Goudsbloemvallei 7, 5237 MH, ’s-Hertogenbosch, the Netherlands. Email: j.vanlint{at}lareb.nl.